Hunter syndrome therapeutics market size reached $1.33 billion in 2026 and is expected to grow to $1.78 billion by 2030 at a 7.6% CAGR. Major players: Takeda Pharmaceutical, Denali Therapeutics Inc.
GLP-1 cardiometabolic expansion market size reached $59.47 billion in 2026 and is expected to grow to $101.82 billion by 2030 at a 14.4% CAGR. Major players: Eli Lilly and Company, Novo Nordisk A/S.
Gene silencing therapeutics market size reached $4.64 billion in 2026 and is expected to grow to $8.49 billion by 2030 at a 16.3% CAGR. Major players: Novartis AG, Alnylam Pharmaceuticals Inc.
Factor XIa inhibitors market size reached $1.24 billion in 2026 and is expected to grow to $2.32 billion by 2030 at a 17.0% CAGR. Major players: Johnson & Johnson, Bayer Aktiengesellschaft.
Test Message
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.